Quick Answer
Regencell Bioscience Holdings Ltd reported Total Assets of $5.76 million for fiscal year 2025.
Regencell Bioscience Holdings Ltd Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $5.76M | -31.8% |
| 2024 | $8.44M | -33.1% |
| 2023 | $12.62M | -30.0% |
| 2022 | $18.02M | +5197.6% |
| 2021 | $340.1K | -33.8% |
| 2020 | $514.0K | — |
- Regencell Bioscience Holdings Ltd showed a decrease of -31.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Regencell Bioscience Holdings Ltd’s total assets has grown by 1019.7% (from $514.0 thousand to $5.76 million).
- The most recent figure is from Regencell Bioscience Holdings Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on October 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: